Emmanuel founded Baehl Innovation in 2015 with the vision to facilitate and accelerate international projects in the healthcare market. He has extensive experience leading international assessments and evaluating risks and opportunities in the life sciences and medical device industries. He has personally piloted over 300+ highly strategic missions and has significant expertise advising companies and innovators facing a range of strategic options along the different steps of development and product commercialisation.
Emmanuel began his career in business development with PX Therapeutics, a subsidiary of Aguettant Laboratories. He went on to work 11 years as Partner and Director of a private, Paris-based strategic consulting firm. Emmanuel developed and led the life science business development of the organisation, and formed strong partnerships with over 100 international corporate clients, including major players in pharma, medtech, labs, institutional bodies and opinion leaders.
Emmanuel holds a Masters of Science in Biology from the University of Bordeaux and a Superior Master’s Business degree from the Business School of Grenoble, specialising in Enterprise Management, Pharmaceuticals, and Biotechnology. He is also holds an Expert position with the Public Investment Bank of France on life science innovation issues.